Global Nanomedicine Market 2012-2016

Global Nanomedicine Market 2012-2016

Category : Pharmaceuticals

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market. 
TechNavio's report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.
The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC, Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and  Tecan Group Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

 

 



01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Global Nanotechnology Market

Market Overview

06.2 Global Nanomedicine Market

Market Size and Forecast

06.3 Five Forces Analysis

07. Key Market Segmentation

07.1 Segmentation by Application

07.2 Global Nanomedicine Market in Anticancer Applications

Market Size and Forecast

07.3 Global Nanomedicine Market in CNS Applications

Market Size and Forecast

07.4 Global Nanomedicine Market in Anti-infective Application

Market Size and Forecast

07.5 Global Nanomedicine Market in Anti-inflammatory Application

Market Size and Forecast

07.6 Global Nanomedicine Market in Cardiovascular Application

Market Size and Forecast

07.7 Global Nanomedicine Market in Other Applications

Market Size and Forecast

08. Geographical Segmentation

09. Key Leading Countries


USA

Germany

Japan

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis


17.1 Abbott Laboratories

Business Overview

Key Information

SWOT Analysis

17.2 AstraZeneca plc

Business Overview

Key Information

SWOT Analysis

17.3 Bristol-Myers Squibb Co.

Business Overview

Key Information

SWOT Analysis

17.4 Celgene Corp.

Business Overview

Key Information

SWOT Analysis

17.5 GlaxoSmithKline plc

Business Overview

Key Information

SWOT Analysis

17.6 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

18. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Nanomedicine Market by Application Types

Exhibit 3: Global Nanomedicine Market 2012-2016 (US$ billion)

Exhibit 4: Global Nanomedicine Market by Application Types

Exhibit 5: Global Nanomedicine Market by Application Types 2012 (in percent)

Exhibit 6: Global Nanomedicine Market by Application Types 2012-2016 (in percent)

Exhibit 7: Global Nanomedicine Market in Anticancer Application 2012-2016 (US$ billion)

Exhibit 8: Global Nanomedicine Market in CNS Application 2012-2016 (US$ billion)

Exhibit 9: Global Nanomedicine Market in Anti-infective Applications 2012-2016 (US$ billion)

Exhibit 10: Global Nanomedicine Market in Anti-inflammatory Applications 2012-2016 (US$ billion)

Exhibit 11: Global Nanomedicine Market in Cardiovascular Application 2012-2016 (US$ billion)

Exhibit 12: Global Nanomedicine Market in Other Applications 2012-2016 (US$ billion)

Exhibit 13: Global Nanomedicine Market by Geographical Segmentation 2012

Exhibit 14: Business Segmentation of Abbott Laboratories

Exhibit 15: Business Segmentation of AstraZeneca plc

Exhibit 16: Business Segmentation of Bristol-Myers Squibb Co.

Exhibit 17: Business Segmentation of Celgene Corp.

Exhibit 18: Business Segmentation of GlaxoSmithKline plc

Exhibit 19: Business Segmentation of Pfizer Inc.





 


Enquiry Before Buy
image
Can´t read the image ? refresh here.